• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 1
  3. Author

Online ISSN: 2515-8260

Volume9, Issue1

Assessment of patients with sepsis and septic shock Using Procalcitonin and C-reactive Protein

    Abdelhamid Mohammad Abdelhamid, Hassan Mohammad Mageed, Ghada Mohammad Abdel Razik,Sherif M. S. Mowafy .

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 1, Pages 885-894

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection inside ICU. The aim of the present study was to assess the Relation between levels of procalcitonin and C-reactive protein as markers with severity of sepsis and septic shock.
Patients and methods: This observational study was involved 60 patients who diagnosed with sepsis or septic shock and admitted to Surgical intensive care unit, Zagazig University Hospitals, Egypt. Procalcitonin and C-reactive protein levels were estimated in the 1st, 3rd, and 5th ICU day. APACHE II as well as SOFA Scores were estimated on ICU admission.
Results: Patients were classified according to the need for mechanical ventilation (MV group and non-MV group), CRP showed no significant difference between the two groups on the first day (100.51 and 83.21 mg/dl respectively- p=0.108). The remaining readings showed a significant rise in the patients that needed invasive mechanical ventilation. Serum PCT levels showed a significant rise in the MV group throughout the all study readings (p < 0.001). Likewise, SOFA score recordings were significantly higher in the MV patients (p < 0.001). On assessment of the predictors for vasopressor need, the highest sensitivity was reported for 3rd day CRP (84.1% - cut off = 62.01 mg/dl), and 5th  day PCT (84.1% - cutoff = 0.505 ng/ml). Slight decrease in sensitivity (81.8%) was reported with the application of 1st day PCT and 3rd day SOFA.
Conclusion: PCT and CRP can be used as a  prognostic markers for evaluating the prognosis of patients with sepsis and septic shock.regarding need for vasopressors the highest sensitivity was reported for 3rd day CRP and fifth day PCT, however the length of stay was found to be highly correlated with 3rd day PCT, also 1st day PCT value was better to Predict need for Mechanical ventilation.
Keywords:
    sepsis SOFA score PCT CRP
  • PDF (320 K)
  • XML
(2022). Assessment of patients with sepsis and septic shock Using Procalcitonin and C-reactive Protein. European Journal of Molecular & Clinical Medicine, 9(1), 885-894.
Abdelhamid Mohammad Abdelhamid, Hassan Mohammad Mageed, Ghada Mohammad Abdel Razik,Sherif M. S. Mowafy .. "Assessment of patients with sepsis and septic shock Using Procalcitonin and C-reactive Protein". European Journal of Molecular & Clinical Medicine, 9, 1, 2022, 885-894.
(2022). 'Assessment of patients with sepsis and septic shock Using Procalcitonin and C-reactive Protein', European Journal of Molecular & Clinical Medicine, 9(1), pp. 885-894.
Assessment of patients with sepsis and septic shock Using Procalcitonin and C-reactive Protein. European Journal of Molecular & Clinical Medicine, 2022; 9(1): 885-894.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 102
  • PDF Download: 117
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus